Award
NIH Reporter #5R01HL165202-04
Transfusion-driven hyperhemolysis in sickle cell disease
Recipient
National Heart Lung and Blood Institute (NHLBI)
Award Amount
$799,330.00
Ceiling
$799,330.00
Awarded
August 31, 2026
Identifier
5R01HL165202-04
Research grant awarded by the National Heart Lung and Blood Institute for studying transfusion-driven hyperhemolysis in sickle cell disease, focusing on mechanisms, biomarkers, and therapies.
Description
This is a research grant awarded by the NHLBI for a project on hyperhemolysis in sickle cell disease, with a focus on interferon's role in RBC destruction and production. The project involves studying mechanisms of bystander hemolysis, identifying biomarkers, and testing therapeutic interventions.